Relay Therapeutics Inc expected to post a loss of 71 cents a share - Earnings Preview

Relay Therapeutics

02/11/2022 02:03

* Relay Therapeutics Inc  RLAY.OQ   RLAY.O  is expected
to show a
rise in quarterly revenue when it reports  results on November
3. 
    * The Cambridge Massachusetts-based  company is expected to
report
 a 148.6% increase in revenue to $1.656 million from $666
thousand a year ago, according to the mean estimate from 9
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Relay Therapeutics
Inc is
for a loss of 71 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Relay
Therapeutics Inc is $44​, above​ its last closing price
of $22.46. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2022  -0.63       -0.63      -0.71     Missed  -13
 Mar. 31 2022  -0.62       -0.62      -0.57     Beat    7.8
 Dec. 31 2021  -0.57       -0.58      -0.62     Missed  -7.2​
 Sep. 30 2021  -0.65       -0.64      -0.66     Missed  -3.4
 ​​Jun.        -0.44       -0.46      -2.10     Missed  -360.8
 30 2021                                                
 Mar. 31 2021  -0.48       -0.48      -0.47     Beat    3.1​
 Dec. 31 2020  0.44        0.17       0.70      Beat    315.9
 Sep. 30 2020  -0.36       -0.35      -0.51     Missed  -47.4
 This summary was machine generated November 2 at 02:02 GMT.  All
figures in US dollars  unless otherwise stated